Comparison Study Between Suction Aspiration and Combination Technique in Acute Cerebral Infarction
Launched by INJE UNIVERSITY HAEUNDAE PAIK HOSPITAL · Feb 4, 2024
Trial Information
Current as of August 20, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
\*Hospital code for the participant hospitals Bundang Cha Hospital (A) Inje University Haeundae Paik Hospital(I) Samsung Medical Center Sungkyunkwan University (B) Kosin University Gospel Hospital (C) Daegu Good morning Hospital (D) Yeungnam University Medical Center (E) Pohang S hospital(G) Inje University Ilsan Paik Hospital(H) SM christianity Pohang Hospital(L) Choongnam National University Hospital(N) Inha University Hospital(P) Catholic University of Korea Bucheon ST. Mary's Hospital (Q) Catholic University of Korea Uijeongbu ST. Mary's Hospital (R) Catholic University of Korea ST. Vin...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • interventionist
- • minimal experiences of thrombectomy ≥ 50 cases
- • successful recanalization (TICI≥2b) of radiological outcome in all cases treated by thrombectomy \> 70% Patient inclusion criteria
- • age ≥ 18
- • acute cerebral infarction with initial NIHSS ≥ 4
- • patients with agreement for clinical trials
- • detection of large artery occlusion based on CT or Magnetic resonance angiography
- • definition of large artery occlusion: 1) anterior circulation internal carotid artery(ICA), M1, M2 segment A1, A2 segment 2)posterior circulation Vertebrobasilar occlusion including P1 segment
- • Last normal time ≤ 24 hours
- • Flow/volume mismatch ≥ 1/2 based on perfusion image
- Exclusion Criteria:
- • Previous disabled patients before mechanical thrombectomy(MT) (Karnofsky performance Status Scale(KPS) ≤ 80)
- • Patient or patient's guardian refused to the clinical trial
- • Small vessel disease of TOAST classification
- • Other determined etiologies of TOAST classification
- • Patients with Initial NIHSS ≤ 3
- • Diffusion/perfusion matched lesion or flow/volume matched lesion
About Inje University Haeundae Paik Hospital
Inje University Haeundae Paik Hospital is a leading medical institution located in Busan, South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital integrates cutting-edge medical practices with a robust academic framework, fostering collaborations among healthcare professionals, researchers, and industry partners. With a focus on patient-centered care, Inje University Haeundae Paik Hospital aims to contribute to the development of new therapies and improve clinical outcomes, while adhering to the highest ethical standards and regulatory requirements in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Incheon, , Korea, Republic Of
Daegu, , Korea, Republic Of
Ulsan, , Korea, Republic Of
Uijeongbu, , Korea, Republic Of
Bucheon, , Korea, Republic Of
Goyang, Gyeonggi Do, Korea, Republic Of
Seongnam Si, Gyeonggi Do, Korea, Republic Of
Changwon, Gyeongsangnam Do, Korea, Republic Of
Daegu, , Korea, Republic Of
Daejeon, , Korea, Republic Of
Pohang, , Korea, Republic Of
Pohang, , Korea, Republic Of
Suwon, , Korea, Republic Of
Patients applied
Trial Officials
Sung-Chul Jin, PhD
Principal Investigator
Department of Neurosurgery, Inje University, Haeundae Paik Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported